Type B paratyphoid combined vaccine (Walvax biotechnology)
乙型副伤寒结合疫苗（玉溪沃森生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameType B paratyphoid combined vaccine (Walvax biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesWalvax Biotechnology Co LtdYuxi Walvax Biotechnology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A